127 related articles for article (PubMed ID: 21251696)
1. Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid.
Stefaniak AB; Virji MA; Day GA
Chemosphere; 2011 May; 83(8):1181-7. PubMed ID: 21251696
[TBL] [Abstract][Full Text] [Related]
2. Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease.
Stefaniak AB; Day GA; Hoover MD; Breysse PN; Scripsick RC
Toxicol In Vitro; 2006 Feb; 20(1):82-95. PubMed ID: 16061346
[TBL] [Abstract][Full Text] [Related]
3. Release of beryllium from beryllium-containing materials in artificial skin surface film liquids.
Stefaniak AB; Virji MA; Day GA
Ann Occup Hyg; 2011 Jan; 55(1):57-69. PubMed ID: 20729394
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.
Stefaniak AB; Chipera SJ; Day GA; Sabey P; Dickerson RM; Sbarra DC; Duling MG; Lawrence RB; Stanton ML; Scripsick RC
J Toxicol Environ Health A; 2008; 71(22):1468-81. PubMed ID: 18836922
[TBL] [Abstract][Full Text] [Related]
5. Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution.
Stefaniak AB; Guilmette RA; Day GA; Hoover MD; Breysse PN; Scripsick RC
Toxicol In Vitro; 2005 Feb; 19(1):123-34. PubMed ID: 15582363
[TBL] [Abstract][Full Text] [Related]
6. Release of beryllium from mineral ores in artificial lung and skin surface fluids.
Duling MG; Stefaniak AB; Lawrence RB; Chipera SJ; Virji MA
Environ Geochem Health; 2012 Jun; 34(3):313-22. PubMed ID: 21866318
[TBL] [Abstract][Full Text] [Related]
7. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.
Stefaniak AB; Hoover MD; Day GA; Dickerson RM; Peterson EJ; Kent MS; Schuler CR; Breysse PN; Scripsick RC
J Environ Monit; 2004 Jun; 6(6):523-32. PubMed ID: 15173904
[TBL] [Abstract][Full Text] [Related]
8. Dissolution and nanoparticle generation behavior of Be-associated materials in synthetic lung fluid using inductively coupled plasma mass spectroscopy and flow field-flow fractionation.
Huang W; Fernandez D; Rudd A; Johnson WP; Deubner D; Sabey P; Storrs J; Larsen R
J Chromatogr A; 2011 Jul; 1218(27):4149-59. PubMed ID: 21167491
[TBL] [Abstract][Full Text] [Related]
9. Effects of beryllium metal particles on the viability and function of cultured rat alveolar macrophages.
Finch GL; Lowther WT; Hoover MD; Brooks AL
J Toxicol Environ Health; 1991 Sep; 34(1):103-14. PubMed ID: 1890688
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model.
Day GA; Hoover MD; Stefaniak AB; Dickerson RM; Peterson EJ; Esmen NA; Scripsick RC
Exp Lung Res; 2005 Apr; 31(3):341-60. PubMed ID: 15962713
[TBL] [Abstract][Full Text] [Related]
11. A theoretical framework for evaluating analytical digestion methods for poorly soluble particulate beryllium.
Stefaniak AB; Brink CA; Dickerson RM; Day GA; Brisson MJ; Hoover MD; Scripsick RC
Anal Bioanal Chem; 2007 Apr; 387(7):2411-7. PubMed ID: 17124574
[TBL] [Abstract][Full Text] [Related]
12. Extraction of beryllium from refractory beryllium oxide with dilute ammonium bifluoride and determination by fluorescence: a multiparameter performance evaluation.
Goldcamp MJ; Goldcamp DM; Ashley K; Fernback JE; Agrawal A; Millson M; Marlow D; Harrison K
J Occup Environ Hyg; 2009 Dec; 6(12):735-44. PubMed ID: 19894174
[TBL] [Abstract][Full Text] [Related]
13. The comparative pulmonary toxicity of beryllium metal and beryllium oxide in cynomolgus monkeys.
Haley PJ; Pavia KF; Swafford DS; Davila DR; Hoover MD; Finch GL
Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):627-44. PubMed ID: 7876465
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationships between inhaled beryllium metal and lung toxicity in C3H mice.
Finch GL; Nikula KJ; Hoover MD
Toxicol Sci; 1998 Mar; 42(1):36-48. PubMed ID: 9538046
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry of beryllium in cultured canine pulmonary alveolar macrophages.
Eidson AF; Taya A; Finch GL; Hoover MD; Cook C
J Toxicol Environ Health; 1991 Dec; 34(4):433-48. PubMed ID: 1960761
[TBL] [Abstract][Full Text] [Related]
16. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
17. Release of beryllium into artificial airway epithelial lining fluid.
Stefaniak AB; Virji MA; Day GA
Arch Environ Occup Health; 2012; 67(4):219-28. PubMed ID: 23074979
[TBL] [Abstract][Full Text] [Related]
18. The effect of beryllium compound solubility on in vitro canine alveolar macrophage cytotoxicity.
Finch GL; Verburg RJ; Mewhinney JA; Eidson AF; Hoover MD
Toxicol Lett; 1988 May; 41(2):97-105. PubMed ID: 3368931
[TBL] [Abstract][Full Text] [Related]
19. In vitro dissolution of uniform cobalt oxide particles by human and canine alveolar macrophages.
Kreyling WG; Godleski JJ; Kariya ST; Rose RM; Brain JD
Am J Respir Cell Mol Biol; 1990 May; 2(5):413-22. PubMed ID: 2340182
[TBL] [Abstract][Full Text] [Related]
20. Influence of artificial gastric juice composition on bioaccessibility of cobalt- and tungsten-containing powders.
Stefaniak AB; Virji MA; Harvey CJ; Sbarra DC; Day GA; Hoover MD
Int J Hyg Environ Health; 2010 Mar; 213(2):107-15. PubMed ID: 20096630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
